ArticleClinical case reports2026
First Case of Neuroblastoma-Like Somatic-Type Malignancy Arising in the Teratomatous Component of a Mixed Non-Seminomatous Testicular Germ Cell Tumor in an Adult.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Somatic malignant transformation (SMT) in germ cell tumors (GCTs) is a rare but clinically significant event. Among non-seminomatous germ cell tumors (NSGCTs), teratomas can undergo malignant transformation, with neuroblastoma-like differentiation being exceptionally rare. No standardized treatment protocols exist, and management is typically extrapolated from conventional approaches for GCTs and neuroblastoma. We report the first documented case of neuroblastoma arising within a testicular teratoma in a 25-year-old male presenting with a painless right testicular mass. Serum tumor markers showed elevated beta-hCG, while AFP and LDH were normal. Imaging revealed no metastases. Radical orchiectomy was performed, and histopathology confirmed a mixed NSGCT with teratomatous and minor embryonal carcinoma components, with immunohistochemistry confirming neuroblastoma differentiation. The tumor was staged as pT1 (AJCC 8th edition). The patient completed four cycles of chemotherapy and remains in complete remission. Neuroblastoma arising within a testicular teratoma is an exceptionally rare occurrence, posing diagnostic and therapeutic challenges. Early diagnosis, histopathological evaluation, and multidisciplinary management are crucial for optimal outcomes. Further research is needed to refine treatment strategies for such rare malignancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.